Clinical Trials in Lai Chi Kok, Hong Kong
3 recruiting
Showing 1–3 of 3 trials
Recruiting
Phase 3
AZD0486 1L Therapy for Elderly or Unfit Participants With LBCL
Large B-cell Lymphoma
AstraZeneca420 enrolled40 locationsNCT07215585
Recruiting
Phase 3
Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004)
Non-small Cell Lung Cancer (NSCLC)
Merck Sharp & Dohme LLC556 enrolled192 locationsNCT06074588
Recruiting
Phase 3
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Non-small Cell Lung Cancer
AstraZeneca582 enrolled164 locationsNCT06350097